Reuters logo
BRIEF-Shire says EU regulator backs new formulation of blood cancer treatment
October 13, 2017 / 5:08 AM / 7 days ago

BRIEF-Shire says EU regulator backs new formulation of blood cancer treatment

Oct 13 (Reuters) - SHIRE PLC:

* NEW FORMULATION OF ONCASPAR® (PEGASPARGASE) RECEIVES POSITIVE CHMP OPINION IN EUROPE FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

* EMA‘S CHMP ADOPTED A POSITIVE OPINION RECOMMENDING MARKETING AUTHORIZATION FOR LYOPHILIZED ONCASPAR​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below